Molecule Details
InChIKeyGDLIGKIOYRNHDA-UHFFFAOYSA-N
Compound NameClomipramine
Canonical SMILESCN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)24
Pfam Stratification Cross-Family
Avg pChEMBL7.15
SourceBindingDB;ChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01242
Drug NameClomipramine
CAS Number303-49-1
Groups approved investigational vet_approved
ATC Codes N06AA04
DescriptionClomipramine, the 3-chloro analog of imipramine, is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, clomipramine does no...

Categories: Agents that produce hypertension Agents that reduce seizure threshold Antidepressive Agents Antidepressive Agents Indicated for Depression Antidepressive Agents, Tricyclic Central Nervous System Agents Central Nervous System Depressants Combined Inhibitors of Serotonin/Norepinephrine Reuptake Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 Inhibitors (strong) Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dibenzazepines Drugs that are Mainly Renally Excreted Heterocyclic Compounds, Fused-Ring Hypotensive Agents Membrane Transport Modulators Moderate Risk QTc-Prolonging Agents Narrow Therapeutic Index Drugs Nervous System Neurotoxic agents Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Non-Selective Monoamine Reuptake Inhibitors P-glycoprotein inhibitors Psychoanaleptics Psychotropic Drugs QTc Prolonging Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT2 Receptor Antagonists Serotonin 5-HT2A Receptor Antagonists Serotonin 5-HT2C Receptor Antagonists Serotonin Agents Serotonin Modulators Serotonin Receptor Antagonists Tertiary amine tricyclic antidepressants Tricyclics and Other Norepinephrine-reuptake Inhibitors
Cross-references: BindingDB: 77970 ChEBI: 47780 CHEMBL415 ChemSpider: 2699 Drugs Product Database (DPD): 2442 Guide to Pharmacology: 2398 IUPHAR: 2398 C06918 D00811 PDB: CXX PharmGKB: PA449048 PubChem:2801 PubChem:46505157 RxCUI: 2597 Therapeutic Targets Database: DAP000742 Wikipedia: Clomipramine ZINC: ZINC000000020248
Target Activities (24)
Target Gene Organism Category Pfam pChEMBL Type Source
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 9.6 Ki ChEMBL;BindingDB
P35348 ADRA1A Homo sapiens Human PF00001 8.5 Ki BindingDB
P35367 HRH1 Homo sapiens Human PF00001 7.5 IC50 ChEMBL
P28335 HTR2C Homo sapiens Human PF00001 7.5 Ki ChEMBL;BindingDB
P08173 CHRM4 Homo sapiens Human PF00001 7.5 IC50 ChEMBL
P28223 HTR2A Homo sapiens Human PF00001 7.5 Ki ChEMBL;BindingDB
P08912 CHRM5 Homo sapiens Human PF00001 7.3 IC50 ChEMBL
P11229 CHRM1 Homo sapiens Human PF00001 7.3 IC50 ChEMBL
P35462 DRD3 Homo sapiens Human PF00001 7.3 Ki ChEMBL;BindingDB
P23975 SLC6A2 Homo sapiens Human PF00209 7.2 Ki ChEMBL;BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 7.2 IC50 ChEMBL
P20309 CHRM3 Homo sapiens Human PF00001 7.1 IC50 ChEMBL
P50406 HTR6 Homo sapiens Human PF00001 6.9 Ki ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 6.9 IC50 ChEMBL
P08172 CHRM2 Homo sapiens Human PF00001 6.8 IC50 ChEMBL
P14416 DRD2 Homo sapiens Human PF00001 6.8 Ki ChEMBL;BindingDB
P41595 HTR2B Homo sapiens Human PF00001 6.7 IC50 ChEMBL
P18825 ADRA2C Homo sapiens Human PF00001 6.7 Ki ChEMBL
P21728 DRD1 Homo sapiens Human PF00001 6.5 Ki ChEMBL;BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 6.3 Ki ChEMBL;BindingDB
Q99720 SIGMAR1 Homo sapiens Human PF04622 6.2 Ki ChEMBL
P08922 ROS1 Homo sapiens Human PF00041 PF07714 6.0 IC50 BindingDB
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 Clinical TTD_MultiTarget TTD_MultiTarget
P28222 HTR1B Homo sapiens Human PF00001 Clinical TTD_MultiTarget TTD_MultiTarget
DrugBank Target Actions (13)
Target Gene Target Name Action Type
P02768 ALB Albumin substrate carriers
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P28223 HTR2A 5-hydroxytryptamine receptor 2A antagonist targets
P28335 HTR2C 5-hydroxytryptamine receptor 2C antagonist targets
P41595 HTR2B 5-hydroxytryptamine receptor 2B antagonist targets
P09211 GSTP1 Glutathione S-transferase P inhibitor targets
P23975 SLC6A2 Sodium-dependent noradrenaline transporter inhibitor targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters